AROMASCAN PLC U.S. SUBSIDIARY BEGINNING OPERATIONS IN SEPTEMBER
This article was originally published in The Rose Sheet
Executive Summary
AROMASCAN PLC U.S. SUBSIDIARY BEGINNING OPERATIONS IN SEPTEMBER will offer U.S. companies aroma-analysis instruments that are said to emulate the human nose. The company noted that its aroma-analysis technology "has substantial commercial potential as it offers significant advantages over existing methods of aroma analysis" such as human sensory panels and "expensive" chemical component analysis, both of which are used extensively for quality control and product development in the toiletries, perfume, food and beverage industries. The parent firm is a start-up company based in Crewe, England. It went public June 17.